Wang Xiaohui, Lan Yang, Zeng Zhongping, Ge Laian
Department of Gastroenterology, The Second Affiliated Hospital of Jiangxi University of TCM Nanchang, Jiangxi, China.
Jiangxi University of Traditional Chinese Medicine Nanchang, Jiangxi, China.
Am J Transl Res. 2021 Jun 15;13(6):6288-6296. eCollection 2021.
This study aimed to investigate the PAR-2/TRVP1-based mechanism of steaming umbilical cord therapy with Chinese Herbal Medicine (SUCT-CHM) in IBS-D rat models.
Sixty-two IBS-D modeled rats were established, and were randomly assigned to the control group (n = 31) and the experimental group (n = 31). The model group did not receive intervention measures, and the experimental group was treated with SUCT-CHM. After 14 days of intervention, the two groups of rats were compared in terms of body weight, gastrointestinal function, Bristol stool score, wet/dry weight ratio of rat stool, and abdominal withdrawal reflex scores. The transient receptor potential vanilloid receptor 1 (TRPV1), protease-activated receptors-2 (PAR-2), calcitonin gene related peptide (CGRP) and Substance P (SP) protein expression were detected using ELISA.
After 14 d of intervention, compared to the control group, the rats in the experimental group showed a significant increase in body mass indexes ( < 0.05); decreased Bristol stool scores ( < 0.05); less stagnation of the intestinal contents and greater intestine propulsion rate ( < 0.05), lower wet/dry weight ratio of rat stool ( < 0.05), abdominal withdrawal reflex scores ( < 0.05) as well as PAR-2, TRVP1, CGRP and SP expression levels ( < 0.05).
SUCT-CHM was effective in treating IBS-D in rats. It improved gastrointestinal function and reduced visceral hypersensitivity in rats possibly via the PAR-2/TRVP1 pathway.
本研究旨在探讨中药蒸脐疗法(SUCT-CHM)对肠易激综合征腹泻型(IBS-D)大鼠模型基于蛋白酶激活受体-2(PAR-2)/瞬时受体电位香草酸受体1(TRPV1)的作用机制。
建立62只IBS-D模型大鼠,随机分为对照组(n = 31)和实验组(n = 31)。模型组不采取干预措施,实验组采用SUCT-CHM治疗。干预14天后,比较两组大鼠的体重、胃肠功能、布里斯托大便评分、大鼠粪便湿/干重比及腹部退缩反射评分。采用酶联免疫吸附测定法(ELISA)检测瞬时受体电位香草酸受体1(TRPV1)、蛋白酶激活受体-2(PAR-2)、降钙素基因相关肽(CGRP)和P物质(SP)蛋白表达。
干预14天后,与对照组相比,实验组大鼠体重指数显著升高(< 0.05);布里斯托大便评分降低(< 0.05);肠内容物停滞减少,肠推进率提高(< 0.05),大鼠粪便湿/干重比降低(< 0.05),腹部退缩反射评分降低(< 0.05),PAR-2、TRPV1、CGRP和SP表达水平降低(< 0.05)。
SUCT-CHM对大鼠IBS-D有效。它可能通过PAR-2/TRPV1途径改善大鼠胃肠功能并降低内脏高敏感性。